2007
DOI: 10.1016/s0828-282x(07)70843-7
|View full text |Cite
|
Sign up to set email alerts
|

Early mortality from off-pump and on-pump coronary bypass surgery in Canada: A comparison of the STS and the EuroSCORE risk prediction algorithms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
14
0
1

Year Published

2008
2008
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(16 citation statements)
references
References 17 publications
1
14
0
1
Order By: Relevance
“…This is in contrast to the findings of some earlier observational studies [7,[16][17][18] but in agreement with others [19][20][21][22]. Our 30-day mortality rates are very similar to those reported in a recent cohort from another Canadian university hospital [23] and by the Multicenter Study of Perioperative Ischemia investigators [20], who also found no association between statin use and in-hospital all-cause mortality (all-cause mortality rate, 1.9% and 2.4% for statin users and nonusers, respectively; crude OR, 0.79; 95% CI, 0.45-1.36). Our results are also consistent with the findings of the only 2 randomized trials of statin use for cardiac surgery patients; these studies demonstrated 30-day mortality rates !2%, with no significant difference between persons who were randomized to receive statin and those randomized to receive placebo [21,24].…”
Section: Discussionsupporting
confidence: 91%
“…This is in contrast to the findings of some earlier observational studies [7,[16][17][18] but in agreement with others [19][20][21][22]. Our 30-day mortality rates are very similar to those reported in a recent cohort from another Canadian university hospital [23] and by the Multicenter Study of Perioperative Ischemia investigators [20], who also found no association between statin use and in-hospital all-cause mortality (all-cause mortality rate, 1.9% and 2.4% for statin users and nonusers, respectively; crude OR, 0.79; 95% CI, 0.45-1.36). Our results are also consistent with the findings of the only 2 randomized trials of statin use for cardiac surgery patients; these studies demonstrated 30-day mortality rates !2%, with no significant difference between persons who were randomized to receive statin and those randomized to receive placebo [21,24].…”
Section: Discussionsupporting
confidence: 91%
“…However, in a general sense the predictive performance of the STS algorithm is comparable with the other scoring systems. 21,23 Parsonnet Score…”
Section: Society Of Thoracic Surgeons Scorementioning
confidence: 99%
“…Toumpoulis et al [25] 0.77 0.66 Xu et al [26 ] 0.71 ND Jin et al [27] 0.791 ND Yap et al [28] 0.82 ND Antunes et al [29] 0.754 ND Farrokhyar et al [30 ] 0 development, the Parsonnet classification overestimated mortality predictions by more than 100% in the low and moderate-risk categories (score of 0-14 points) and by more than 250% in the high and very high-risk groups of patients (score greater than 14 points) [22,34,35]. The risk overestimation is particularly obvious in octogenarians who, with a minimum of 20 points, had a predicted mortality of 31% with the original Parsonnet score.…”
Section: Predictive Performance Of Risk Models In Cardiac Surgerymentioning
confidence: 99%